Baby Safety / Compounds / Cotinine (nicotine metabolite/biomarker)

Is Cotinine (nicotine metabolite/biomarker) safe for babies and kids?

Elevated risk for kids

Infants are more vulnerable to Cotinine (nicotine metabolite/biomarker) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is cotinine (nicotine metabolite/biomarker)?

The IUPAC name is (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one.

Also known as: (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one, cotinine, (-)-Cotinine, (S)-Cotinine.

IUPAC name
(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
CAS number
486-56-6
Molecular formula
C10H12N2O
Molecular weight
176.21 g/mol
SMILES
CN1C(CCC1=O)C2=CN=CC=C2
PubChem CID
854019

Risk for babies

Elevated risk

Infants are more vulnerable to Cotinine (nicotine metabolite/biomarker) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Cotinine (nicotine metabolite/biomarker), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Cotinine (nicotine metabolite/biomarker).

AgencyYearClassificationNotes
IARC2004Not evaluated — cotinine has not been independently classified by IARC as to carcinogenicity; it is the primary urinary biomarker of tobacco smoke exposure (active smoking and secondhand smoke) and is used in clinical, epidemiological, and regulatory contexts to quantify nicotine/tobacco carcinogen burden rather than as a recognized carcinogen itself

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter cotinine (nicotine metabolite/biomarker)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Cotinine (nicotine metabolite/biomarker):

  • Exposure reduction (combustion byproduct)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×

Frequently asked questions

Is cotinine (nicotine metabolite/biomarker) safe for kids?

Infants are more vulnerable to Cotinine (nicotine metabolite/biomarker) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain cotinine (nicotine metabolite/biomarker)?

Cotinine (nicotine metabolite/biomarker) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to cotinine (nicotine metabolite/biomarker)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Cotinine (nicotine metabolite/biomarker) in the baby app

Look up products containing cotinine (nicotine metabolite/biomarker), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. Cotinine Nicotine Metabolite CYP2A6 Biomarker Secondhand Smoke SHS Exposure; Serum Threshold 10 ng/mL Active Smoking; Breast Milk Infant Exposure; FDA WHO EFSA Tobacco Regulation Biomonitoring; nAChR Nicotinic Acetylcholine Receptor; PPCP Emerging Contaminant; Child SHS Asthma Neurodevelopment; E-cigarette Cotinine Combustion-Free (2004) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →